Mosaic ImmunoEngineering (CPMV) Depreciation & Amortization (CF) (2010 - 2020)
Mosaic ImmunoEngineering (CPMV) posted quarterly Depreciation & Amortization (CF) of $122.0 for Q2 2020, down 0.81% year-over-year from $123.0 in Q2 2019, and little changed quarter-over-quarter from $122.0 in Q1 2020.
Mosaic ImmunoEngineering (CPMV) Depreciation & Amortization (CF) (2010 - 2020) Analysis & Trends
Mosaic ImmunoEngineering's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $122.0 for Q2 2020.
- In Q2 2020, Depreciation & Amortization (CF) fell 0.81% year-over-year to $122.0; the TTM figure through Mar 2021 stood at $122.0 (changed N/A YoY), while the FY2020 annual figure was $488.0, changed 0.2% from the prior year.
- Depreciation & Amortization (CF) for Q2 2020 stood at $122.0, roughly flat from $122.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $302.0 in Q1 2016, with the low at $61.0 in Q2 2016.
- The 5-year median for Depreciation & Amortization (CF) is $122.5 (2018), against an average of $162.72.
- The sharpest annual moves came in 2016 and 2017: Depreciation & Amortization (CF) sank 87.21% in 2016, then jumped 268.85% in 2017.
- Mosaic ImmunoEngineering's Depreciation & Amortization (CF) stood at $225.0 in 2016, then changed by 0.0% to $225.0 in 2017, then slumped by 45.78% to $122.0 in 2018, then changed by 0.0% to $122.0 in 2019, then changed by 0.0% to $122.0 in 2020.
- Business Quant data shows CPMV's Depreciation & Amortization (CF) at $122.0 in Q2 2020, $122.0 in Q1 2020, and $122.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2020 | 122.00 |
| May 31, 2020 | 122.00 |
| Feb 29, 2020 | 122.00 |
| Feb 29, 2020 | 122.00 |
| Nov 30, 2019 | 122.00 |
| Nov 30, 2019 | 122.00 |
| Aug 31, 2019 | 122.00 |
| Aug 31, 2019 | 122.00 |
| May 31, 2019 | 123.00 |
| May 31, 2019 | 123.00 |
| Feb 28, 2019 | 122.00 |
| Feb 28, 2019 | 122.00 |
| Nov 30, 2018 | 122.00 |
| Nov 30, 2018 | 122.00 |
| Aug 31, 2018 | 122.00 |
| Aug 31, 2018 | 122.00 |
| May 31, 2018 | 122.00 |
| May 31, 2018 | 122.00 |
| Feb 28, 2018 | 191.00 |
| Feb 28, 2018 | 191.00 |